Breakthrough Therapy Designation Market Size - Forecasts to 2026

Globalmarketestimate17 May, 2021Business

As per the research conducted by GME, the Breakthrough Therapy Designation Market will grow with a CAGR value of 14.4 per cent. The key driver for the breakthrough therapy drugs market is the rising prevalence of life-threatening conditions and the need for rapid development of pipeline drugs. The FDA's increased support for small-scale industries in R&D, including increased money and faster drug approval, is fueling the market for breakthrough therapy drugs.